Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Looking to Bring Anti-epileptic Drug Testing Back In-House?

Published: Thursday, February 21, 2013
Last Updated: Thursday, February 21, 2013
Bookmark and Share
ARK Diagnostics introduces Anti-epileptic Drug Monitoring assays into users laboratory.

Compatibility with most common clinical chemistry platforms, means no new equipment or specialist training is required, to introduce the ARK Diagnostics range of Anti-epileptic Drug Monitoring assays into users laboratory.

Measuring serum drug concentrations provides valuable information to aid clinical decisions about patient dose.

ARK Diagnostics immunoassays, for new generation drugs such as levetiracetam, lamotrigine, gabapentin, topiramate and zonisamide, are now available in the UK, exclusively from Alpha Laboratories.

These precise enzyme immunoassays are provided in a convenient ready-to-use format for easy automation.

Unaffected by common interfering substances such as rheumatoid factor, haemoglobin or triglycerides, these robust assays provide the sensitivity needed for clinical decisions.

With excellent correlation to traditional methods such as LC-MS/MS, HPLC and FPIA, the ARK AED assays can be run on most popular analyzers, including the Cobas c501 and Beckman AU640, enabling fast turn-around times.

Anti-epileptic drugs (AEDs) are often candidates for therapeutic drug monitoring and individualization of a dose is essential in epilepsy therapy.

However, identification of the optimal dose, on clinical grounds alone, can be a challenge, as AED treatment is prophylactic and occurrence of seizures sporadic.

Monitoring of serum concentrations helps optimize long-term seizure control and prevent toxicity.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!